Gene amplification in cancer.

Gene amplification is a copy number increase of a restricted region of a chromosome arm. It is prevalent in some tumors and is associated with overexpression of the amplified gene(s). Amplified DNA can be organized as extrachromosomal elements, as repeated units at a single locus or scattered throughout the genome. Common chromosomal fragile sites, defects in DNA replication or telomere dysfunction might promote amplification. Some regions of amplification are complex, yet elements of the pattern are reproduced in different tumor types. A genetic basis for amplification is suggested by its relative frequency in some tumor subtypes, and its occurrence in "early" preneoplastic lesions. Clinically, amplification has prognostic and diagnostic usefulness, and is a mechanism of acquired drug resistance.

[1]  F. Toledo,et al.  Expression of Fragile Sites Triggers Intrachromosomal Mammalian Gene Amplification and Sets Boundaries to Early Amplicons , 1997, Cell.

[2]  G. Stark,et al.  Regulation and mechanisms of gene amplification. , 1995, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[3]  Peter Schraml,et al.  Prognostic Relevance of Gene Amplifications and Coamplifications in Breast Cancer , 2004, Cancer Research.

[4]  F. Kaye.  A curious link between epidermal growth factor receptor amplification and survival: effect of "allele dilution" on gefitinib sensitivity? , 2005, Journal of the National Cancer Institute.

[5]  F. Alt,et al.  Unrepaired DNA Breaks in p53-Deficient Cells Lead to Oncogenic Gene Amplification Subsequent to Translocations , 2002, Cell.

[6]  N. Johnson,et al.  Tobacco use and oral cancer: a global perspective. , 2001, Journal of dental education.

[7]  Thomas E Rohan,et al.  Cigarette smoking and the risk of breast cancer in women: a review of the literature. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  B H Margolin,et al.  Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbrück fluctuation analysis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[9]  W. Hittelman,et al.  Chromosome breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant CHO cells , 1994, Molecular and cellular biology.

[10]  Ming You,et al.  Wildtype Kras2 can inhibit lung carcinogenesis in mice , 2001, Nature Genetics.

[11]  A. Coquelle,et al.  Interstitial deletions and intrachromosomal amplification initiated from a double‐strand break targeted to a mammalian chromosome , 1998, The EMBO journal.

[12]  J. Bertino,et al.  Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells. , 1978, The Journal of biological chemistry.

[13]  J. Murnane,et al.  Chromosome rearrangements resulting from telomere dysfunction and their role in cancer , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[14]  P. Meltzer,et al.  Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection , 1994, Nature Genetics.

[15]  Xin Huang,et al.  High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  L. Chin,et al.  Telomere dysfunction provokes regional amplification and deletion in cancer genomes. , 2002, Cancer cell.

[17]  D. Gisselsson,et al.  Connecting mitotic instability and chromosome aberrations in cancer--can telomeres bridge the gap? , 2005, Seminars in cancer biology.

[18]  D. Albertson,et al.  Chromosome aberrations in solid tumors , 2003, Nature Genetics.

[19]  A. Bernheim,et al.  Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: the model of PIP gene duplication from a break at FRA7I. , 2002, Human molecular genetics.

[20]  F. Marandino,et al.  Phenotypic changes of p53, HER2, and FAS system in multiple normal tissues surrounding breast cancer , 2005, Journal of cellular physiology.

[21]  R. DePinho,et al.  Connecting chromosomes, crisis, and cancer. , 2002, Science.

[22]  W. Hong,et al.  Visualization of the timing of gene amplification during multistep head and neck tumorigenesis. , 2000, Cancer research.

[23]  C. Paquin,et al.  Mutations in RAD3, MSH2, and RAD52 affect the rate of gene amplification in the yeast Saccharomyces cerevisiae , 2000, Environmental and molecular mutagenesis.

[24]  Michael R. Speicher,et al.  Digital karyotyping , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Hiroki Nagase,et al.  Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice. , 2003, Cancer research.

[26]  A. Zetterberg,et al.  DNA Amplifications and Aneuploidy, High Proliferative Activity and Impaired Cell Cycle Control Characterize Breast Carcinomas with Poor Prognosis , 2003, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[27]  D. Gisselsson,et al.  Telomere‐mediated mitotic disturbances in immortalized ovarian epithelial cells reproduce chromosomal losses and breakpoints from ovarian carcinoma , 2005, Genes, chromosomes & cancer.

[28]  J. Londoño-Vallejo.  Telomere length heterogeneity and chromosome instability. , 2004, Cancer letters.

[29]  L. Magnelli,et al.  Overexpression of the 18 kDa and 22/24 kDa FGF‐2 isoforms results in differential drug resistance and amplification potential , 2002, Journal of cellular physiology.

[30]  G. Wahl,et al.  Molecular dissection of mammalian gene amplification: new mechanistic insights revealed by analyses of very early events. , 1992, Mutation research.

[31]  D. Birnbaum,et al.  Fusion and amplification of two originally non‐syntenic chromosomal regions in a mammary carcinoma cell line , 1992, Genes, chromosomes & cancer.

[32]  G. Giaccone,et al.  EGFR inhibitors: what have we learned from the treatment of lung cancer? , 2005, Nature Clinical Practice Oncology.

[33]  M. Schwab,et al.  Amplification of oncogenes revisited: from expression profiling to clinical application. , 2001, Cancer letters.

[34]  F. Watt,et al.  DNA amplification is rare in normal human cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Murnane,et al.  The Loss of a Single Telomere Can Result in Instability of Multiple Chromosomes in a Human Tumor Cell Line , 2005, Molecular Cancer Research.

[36]  W. Kuo,et al.  Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene , 2000, Nature Genetics.

[37]  Ajay N. Jain,et al.  Breast tumor copy number aberration phenotypes and genomic instability , 2006, BMC Cancer.

[38]  D. Beer,et al.  Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma , 2006, Oncogene.

[39]  T. Godfrey,et al.  Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. , 2000, Cancer research.

[40]  J. Fridlyand,et al.  Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.

[41]  Michael R. Speicher,et al.  The new cytogenetics: blurring the boundaries with molecular biology , 2005, Nature Reviews Genetics.

[42]  G. Stark,et al.  Multiple mechanisms of N-phosphonacetyl-L-aspartate resistance in human cell lines: carbamyl-P synthetase/aspartate transcarbamylase/dihydro-orotase gene amplification is frequent only when chromosome 2 is rearranged. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Stephen Chia,et al.  Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas. , 2006, Gynecologic oncology.

[44]  D. Pinkel,et al.  Array comparative genomic hybridization and its applications in cancer , 2005, Nature Genetics.

[45]  M. Waltham,et al.  Intrinsic and acquired resistance to methotrexate in acute leukemia. , 1996, The New England journal of medicine.

[46]  D. Albertson,et al.  Expression patterns of predicted genes from the C. elegans genome sequence visualized by FISH in whole organisms , 1995, Nature Genetics.

[47]  G. Stark,et al.  Hamster cells with increased rates of DNA amplification, a new phenotype , 1987, Cell.

[48]  T. Tlsty.  Normal diploid human and rodent cells lack a detectable frequency of gene amplification. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[49]  F. Toledo,et al.  A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. , 1998, Molecular cell.

[50]  P. N. Rao,et al.  Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification , 2001, Science.

[51]  J. Tower.  Developmental gene amplification and origin regulation. , 2004, Annual review of genetics.

[52]  A. Varshavsky.  On the possibility of metabolic control of replicon "misfiring": relationship to emergence of malignant phenotypes in mammalian cell lineages. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Jane Fridlyand,et al.  Shaping of tumor and drug-resistant genomes by instability and selection , 2003, Oncogene.

[54]  T. Godfrey,et al.  Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. , 2000, Cancer research.

[55]  C. Mondello,et al.  Increased gene amplification in immortal rodent cells deficient for the DNA-dependent protein kinase catalytic subunit. , 2001, Cancer research.

[56]  I. Weinstein,et al.  Overexpression of cyclin D1 enhances gene amplification. , 1996, Cancer research.

[57]  G. Parmigiani,et al.  Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[58]  W. Taylor,et al.  Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability. , 1997, Cancer research.

[59]  J. Fridlyand,et al.  Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma , 2005, Oncogene.

[60]  Peter Devilee,et al.  Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations. , 2005, Cancer research.

[61]  G. Wahl,et al.  Gene Amplification in a p53-Deficient Cell Line Requires Cell Cycle Progression under Conditions That Generate DNA Breakage , 1998, Molecular and Cellular Biology.

[62]  S. Bautista,et al.  CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei , 1998, Genes, chromosomes & cancer.

[63]  C. Lengauer,et al.  Aneuploidy and cancer , 2004, Nature.

[64]  C. Vogel,et al.  Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumab. , 2005, Clinical breast cancer.

[65]  Teruhiko Yoshida,et al.  Alternative mechanisms of gene amplification in human cancers , 2004, Genes, chromosomes & cancer.

[66]  Jane Fridlyand,et al.  Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors , 2004 .

[67]  R. Fine,et al.  Increased fragile sites and sister chromatid exchanges in bone marrow and peripheral blood of young cigarette smokers. , 1987, Cancer research.

[68]  R T Schimke,et al.  Overreplication and recombination of DNA in higher eukaryotes: potential consequences and biological implications. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[69]  T. Glover,et al.  Mechanisms of common fragile site instability. , 2005, Human molecular genetics.

[70]  W. Kuo,et al.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.

[71]  C. Mondello,et al.  Gene amplification in Chinese hamster DNA repair deficient mutants. , 1995, Mutation research.

[72]  F. Apiou,et al.  Molecular structure of double-minute chromosomes bearing amplified copies of the epidermal growth factor receptor gene in gliomas. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[73]  I. Weinstein.  Addiction to Oncogenes--the Achilles Heal of Cancer , 2002, Science.

[74]  G. Stark,et al.  MYC Abrogates p53-Mediated Cell Cycle Arrest in N-(Phosphonacetyl)-l-Aspartate-Treated Cells, Permitting CAD Gene Amplification , 1998, Molecular and Cellular Biology.

[75]  David I. Smith,et al.  A role for common fragile site induction in amplification of human oncogenes. , 2002, Cancer cell.

[76]  R. DePinho,et al.  Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse. , 2001, Seminars in cancer biology.

[77]  F. Alt,et al.  The cellular response to general and programmed DNA double strand breaks. , 2004, DNA repair.

[78]  G. Wahl,et al.  Effect of chromosomal position on amplification of transfected genes in animal cells , 1984, Nature.

[79]  B. Mcclintock,et al.  The Fusion of Broken Ends of Chromosomes Following Nuclear Fusion. , 1942, Proceedings of the National Academy of Sciences of the United States of America.

[80]  Thomas Ried,et al.  Evidence for Replicative Repair of DNA Double-Strand Breaks Leading to Oncogenic Translocation and Gene Amplification , 2002, The Journal of experimental medicine.

[81]  B. Dutrillaux,et al.  Identification of amplified DNA sequences in breast cancer and their organization within homogeneously staining regions , 1995, Genes, chromosomes & cancer.